Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis in systemic lupus erythematosus

D D'Cruz1

  • 1Bone and Joint Research Unit, Royal London Hospital, UK.

Lupus
|June 27, 1998
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) vasculitis causes severe illness and death, with unknown causes. Immunosuppression is vital for critically ill lupus patients experiencing vasculitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.

Lupus·2017
Same author

Burden of illness in systemic lupus erythematosus: results from a UK patient and carer online survey.

Lupus·2017
Same author

Alveolar haemorrhage in eosinophilic granulomatosis and polyangiitis (Churg-Strauss).

Clinical rheumatology·2014
Same author

Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.

Lupus·2013
Same author

The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice.

Lupus·2011
Same author

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.

Annals of the rheumatic diseases·2010

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Vasculitis is a common and severe complication of systemic lupus erythematosus (SLE).
  • It significantly contributes to patient morbidity and mortality.
  • The underlying pathophysiology of SLE-associated vasculitis remains poorly understood.

Purpose of the Study:

  • To highlight the clinical significance of vasculitis in SLE.
  • To emphasize the importance of considering immunosuppression in managing severe cases.

Main Methods:

  • This abstract does not detail specific methods.
  • It is a clinical statement based on established medical knowledge.

Main Results:

  • Vasculitis frequently complicates SLE.

Related Experiment Videos

  • It is linked to considerable morbidity and mortality.

    • Conclusions:

    • Immunosuppression should be strongly considered in seriously ill SLE patients with vasculitis.
    • Prompt and aggressive management is crucial for improving outcomes.